NCT05261165View on ClinicalTrials.gov

Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer

CompletedOBSERVATIONAL
Enrollment

170

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

January 1, 2021

Study Completion Date

October 1, 2021

Conditions
Endometrial CancerLVSI
Interventions
PROCEDURE

hysterectomy

Hysterectomy as primary surgical treatment of endometrial cancer. Abdominal laparotomy approach was performed without intrauterine manipulator (NonManip). Endoscopic - total laparoscopic hysterectomy, laparoscopic assisted vaginal hysterectomy or robotic hysterectomy was performed with use of intrauterine manipulator (Manip). It was Hegar dilatator (ManipHe) or Koh-Rumi device (ManipKoRu).

Trial Locations (1)

Unknown

F.D. Roosevelt Teaching Hospital with Policlinic, Banská Bystrica

All Listed Sponsors
lead

F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica

OTHER

NCT05261165 - Effect of a Uterine Manipulator on the Incidence of Lymphovascular Propagation (LVSI) in Treatment of Endometrial Cancer | Biotech Hunter | Biotech Hunter